ADMA
ADMA Biologics Inc
9.80$
+3.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -12.9% | -0.1% | +356.1% | -17.7% | +43.0% | +63.4% | +33.0% | +26.1% | -5.5% | +48.5% | +27.7% | |
| – | -11.6% | +1.7% | +191.7% | -29.5% | +92.7% | +79.1% | +35.8% | +29.5% | -5.0% | +28.9% | +40.8% | |
| – | -39.3% | -5.0% | +334.8% | -47.2% | +17.6% | +109.0% | -8.6% | +69.4% | -40.6% | +100.9% | -15.0% | |
| – | -23.1% | -8.9% | +181.7% | -47.2% | +17.6% | +109.0% | -8.6% | +69.4% | -40.6% | +100.9% | -15.0% | |
| – | +140.8% | +10.1% | +281.1% | -64.1% | +149.2% | +281.5% | +115.9% | -45.7% | +76.9% | +82.3% | +216.9% | |
| – | +101.7% | +45.7% | +151.6% | +47.4% | +185.0% | +53.7% | +53.0% | +30.9% | +5.9% | -1.5% | +21.3% | |
| – | -15.6% | -16.5% | +1,422.7% | -1.2% | +5.4% | +144,356.1% | -99.9% | +14.4% | – | – | – | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | -17.4% | -21.1% | -22.6% | -29.3% | -41.4% | -50.7% | -7.8% | +37.4% | |
| – | +7.9% | +22.9% | +140.5% | +2.1% | +46.0% | +18.4% | +13.1% | +45.5% | -1.3% | -28.0% | +5.2% | |
| – | +0.4% | +166.2% | -15.9% | +2.0% | +45.7% | +42.2% | +52.3% | +29.3% | +26.8% | +11.5% | +25.2% | |
| – | +9.4% | +40,376.1% | -45.8% | -99.1% | +664.0% | +59.6% | +61.6% | +53.1% | +15.5% | +16.6% | +220.9% | |
| – | +17.3% | +22.8% | +130.9% | -0.3% | +55.5% | +20.7% | +12.2% | +6.4% | +18.4% | +29.1% | +11.4% | |
| – | -3.6% | -13.5% | +128.3% | +3.8% | +133.9% | +36.1% | +2.0% | +50.6% | -8.6% | -44.6% | -4.2% | |
| – | -86.3% | -642.9% | – | -51.0% | +32.5% | +236.9% | +60.0% | +7.7% | -11.0% | +158.1% | +36.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.1% | +16.7% | +88.4% | +97.4% | +20.3% | +58.5% | +62.0% | +41.8% | +13.2% | +8.6% | +0.6% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.